Integrity Cases: Inside British Racing’s Anti-Doping Regime, How the BHA Keeps Racing Clean

British horse racing’s integrity framework is one of the most comprehensive in world sport. The British Horseracing Authority (BHA), as the sport’s regulator, operates a multi-layered system of equine anti-doping, jockey testing, betting market surveillance, intelligence gathering and disciplinary process designed to ensure, as the BHA states in its own governance documentation, that “what you see unfold on the track is the result of the talent, heart and will to win demonstrated by each horse and its rider.”

The Two-Track System: Equine and Human Testing

Equine testing is governed by the BHA’s Equine Anti-Doping Programme. Its foundation is Rule (D) 24, which requires every trainer to maintain an Equine Medication Record Book, a contemporaneous log of every substance administered to every horse in their care, for a minimum of 12 months. This documentation requirement creates a paper trail that allows the BHA to cross-reference what a horse received against what is detected in post-race samples.

Samples are collected at racecourses (post-race from placed horses and random selections) and during out-of-competition testing (at training yards). All horses racing under BHA Rules must do so “free from the effects of any Prohibited substance or method.” The prohibited substances list is substantial, covering a wide range of analgesics, anti-inflammatories, corticosteroids, stimulants and beta-blockers, and is updated regularly. July 2025 updates covered beta-2 agonists, Sildenafil, and the administration of injections; October 2025 updates addressed whereabouts requirements and food chain rules.

Medication used legitimately for treatment must be managed to ensure it has cleared the horse’s system before competition. The key distinction is between a detection time (how long a substance remains detectable in samples) and a withdrawal period (the time a trainer must allow, including a safety margin, before entering a treated horse). BHA guidance emphasises that trainers and their vets must discuss all treatment decisions, and that trainers bear primary responsibility for their horses’ sample results.

Jockey testing operates under a separate Anti-Doping Regulations framework. Jockeys are tested for performance-inhibiting substances, alcohol, cocaine and cannabis, as well as any substance that could impair “capability, judgement, coordination or alertness.” Testing is coordinated by the BHA’s Chief Medical Adviser, Dr Jerry Hill. Jockeys with substance concerns can access confidential support through Sporting Chance (confidential helpline: 077 8000 8877) as well as through the Professional Jockeys Association.

Betting Market Intelligence

A significant but less publicly visible component of the BHA’s integrity operation is its monitoring of betting markets. The BHA’s Intelligence team, staffed by dedicated analysts, monitors market movements across multiple bookmakers simultaneously, looking for patterns that suggest non-public information is influencing prices: known as “suspicious betting activity.”

As the BHA’s intelligence documentation explains, analysts “study the races themselves, using speed maps and a database provided by an industry-leading software company to establish the likely shape of races, both from a performance perspective and a betting angle.” Information gathered from market surveillance is shared with racecourse Stipendiary Stewards before races, and on occasion can prompt a pre-race stewards’ enquiry if patterns are sufficiently concerning.

The BHA also operates RaceWISE, an anonymous tip-off system that allows members of the public, jockeys, stable staff, owners or other racing participants to report concerns about integrity without identification. The BHA’s formal position on tip-offs is that each must be “properly collected and analysed” and that acting precipitously on unverified intelligence, for example, by withdrawing a horse before a sample has been taken, would undermine rather than protect integrity by alerting potential bad actors.

The Disciplinary Process

When the BHA’s Integrity and Compliance teams have gathered sufficient evidence of a rules breach, the case is referred to the Disciplinary Panel. The Panel is independent of the BHA executive and must follow a process that allows the charged individual to prepare and present their case. The BHA presents its evidence, the charged party responds, and the Panel determines both guilt and sanction.

Sanctions available to the Panel include financial penalties, suspension or withdrawal of licences (for trainers and jockeys), and being “warned off”, excluded from all BHA licensed premises and restricted from associating with licensed or registered persons. This last sanction is the most severe available short of criminal prosecution and effectively ends involvement with British racing entirely.

Decisions of the Disciplinary Panel can be appealed to the Appeal Board, except for decisions made on appeal from stewards’ enquiries.

Medication Control Updates in 2025 – 26

The BHA’s prohibited substances regulations are continuously updated to reflect advances in veterinary science and emerging integrity risks. Recent significant updates include:

March 2025: New stand-down period introduced following intra-articular administration of corticosteroids (a mandatory 14-day stand-down period). Updated stand-down period for bisphosphonates. New detection time guidance for clenbuterol.

July 2025: Updated guidance on beta-2 agonists and Sildenafil; clarification on administering injections; guidance on human medication in racecourse stables.October 2025: New whereabouts and permanent import information requirements; updated pre-race examination rules; food chain rules clarification.

These regulatory updates reflect the complexity of managing medication control in a sport where horses receive legitimate veterinary treatment and where the line between therapeutic and performance-enhancing use of authorised medicines is not always clear-cut.

The Wider Principle

The BHA’s own statement on its anti-doping approach frames the system in terms that reflect its broader significance: “Sport is nothing without integrity and in the modern age, with all sports fighting ferociously for diminishing fan and corporate spending, it perhaps matters more to our sport than any other. Any perception that we have not properly dealt with corruption or poor governance would rightly raise questions about our ability to govern ourselves.”

For a sport that relies fundamentally on the betting market, where public confidence that race results are not manipulated is the basis of commercial viability, integrity is not a peripheral welfare concern but the central commercial and reputational asset.